Krka, d. d.

LJSE:KRKG Stock Report

Market Cap: €6.4b

Krka d. d Past Earnings Performance

Past criteria checks 2/6

Krka d. d has been growing earnings at an average annual rate of 5.4%, while the Pharmaceuticals industry saw earnings growing at 10.7% annually. Revenues have been growing at an average rate of 5.9% per year. Krka d. d's return on equity is 15.2%, and it has net margins of 19.3%.

Key information

5.45%

Earnings growth rate

6.01%

EPS growth rate

Pharmaceuticals Industry Growth12.39%
Revenue growth rate5.86%
Return on equity15.21%
Net Margin19.31%
Next Earnings Update13 Nov 2025

Recent past performance updates

Recent updates

Here's Why We Think Krka d. d (LJSE:KRKG) Is Well Worth Watching

Sep 01
Here's Why We Think Krka d. d (LJSE:KRKG) Is Well Worth Watching

Krka, d. d.'s (LJSE:KRKG) Intrinsic Value Is Potentially 33% Above Its Share Price

Aug 14
Krka, d. d.'s (LJSE:KRKG) Intrinsic Value Is Potentially 33% Above Its Share Price

We Think Krka, d. d.'s (LJSE:KRKG) CEO Compensation Looks Fair

Jul 03
We Think Krka, d. d.'s (LJSE:KRKG) CEO Compensation Looks Fair

Getting In Cheap On Krka, d. d. (LJSE:KRKG) Is Unlikely

Jun 23
Getting In Cheap On Krka, d. d. (LJSE:KRKG) Is Unlikely

Krka d. d's (LJSE:KRKG) Upcoming Dividend Will Be Larger Than Last Year's

May 18
Krka d. d's (LJSE:KRKG) Upcoming Dividend Will Be Larger Than Last Year's

Is There An Opportunity With Krka, d. d.'s (LJSE:KRKG) 28% Undervaluation?

May 08
Is There An Opportunity With Krka, d. d.'s (LJSE:KRKG) 28% Undervaluation?

Should You Be Adding Krka d. d (LJSE:KRKG) To Your Watchlist Today?

Apr 01
Should You Be Adding Krka d. d (LJSE:KRKG) To Your Watchlist Today?

Is Krka, d. d. (LJSE:KRKG) Trading At A 32% Discount?

Jan 14
Is Krka, d. d. (LJSE:KRKG) Trading At A 32% Discount?

Krka, d. d.'s (LJSE:KRKG) Share Price Could Signal Some Risk

Dec 13
Krka, d. d.'s (LJSE:KRKG) Share Price Could Signal Some Risk

Revenue & Expenses Breakdown

How Krka d. d makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

LJSE:KRKG Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 251,973381508188
31 Mar 251,946410501188
31 Dec 241,910357489185
30 Sep 241,901360482188
30 Jun 241,871366471185
31 Mar 241,834324459182
31 Dec 231,806314455179
30 Sep 231,816298435170
30 Jun 231,780298447167
31 Mar 231,743362454165
31 Dec 221,717363440163
30 Sep 221,631369440161
30 Jun 221,615367420160
31 Mar 221,602313401157
31 Dec 211,566309393155
30 Sep 211,551320369154
30 Jun 211,540308369155
31 Mar 211,468292365155
31 Dec 201,535291378153
30 Sep 201,563284407154
30 Jun 201,536267422152
31 Mar 201,578261431154
31 Dec 191,493246434152
30 Sep 191,451226441146
30 Jun 191,414213427143
31 Mar 191,372196427136
31 Dec 181,332175420131
30 Sep 181,310163419128
30 Jun 181,291163413126
31 Mar 181,283159411126
31 Dec 171,266153414126
30 Sep 171,250138410126
30 Jun 171,226130405121
31 Mar 171,195111408120
31 Dec 161,174108394118
30 Sep 161,154105389116
30 Jun 161,169116387118
31 Mar 161,176143380117
31 Dec 151,165158387115
30 Sep 151,197172405114
30 Jun 151,192172406111
31 Mar 151,183179413111
31 Dec 141,192166407108

Quality Earnings: KRKG has high quality earnings.

Growing Profit Margin: KRKG's current net profit margins (19.3%) are lower than last year (19.6%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: KRKG's earnings have grown by 5.4% per year over the past 5 years.

Accelerating Growth: KRKG's earnings growth over the past year (4.1%) is below its 5-year average (5.4% per year).

Earnings vs Industry: KRKG earnings growth over the past year (4.1%) did not outperform the Pharmaceuticals industry 9%.

Return on Equity

High ROE: KRKG's Return on Equity (15.2%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/02 03:27
End of Day Share Price 2025/10/30 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Krka, d. d. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Simon MatherBarclays
Stephane SumarBNP Paribas
Jamie ClarkBofA Global Research